APP and Alzheimer disease: Recently, Gynther et al. (2018) showed that LAT1 function was not altered at the BBB of lipopolysaccharide (LPS) induced neuroinflammation murine model and in the transgenic Alzheimer’s disease model with amyloid precursor protein (APP) and presenilin (PSEN1) gene mutations, (31).